Recent 8-K filings for CHSCP
Highest-materiality recent filing
CHS Q2 net loss $75.8M vs $170.3M income; revenue falls 14% to $7.8B
- Net loss of $75.8M in Q2 FY2025, compared to net income of $170.3M in Q2 FY2024.
- Revenue $7.8B, down 14% from $9.1B; first-half net income $169M vs $693M.
-
CHS reports Q2 FY2026 net loss of $147.1M, revenue $8.4B; loss widens from $75.8M
Net loss of $147.1M ($0.81 diluted EPS loss); revenue $8.4B up from $7.8B a year ago.
-
CHS Inc. declares regular Q2 preferred dividends; payable June 30
8% Cum. Redeemable: $0.50/share; Series 1: $0.492188; Series 2: $0.443750; Series 3: $0.421875; Series 4: $0.468750.
-
CHS Inc. Board member Daniel Schurr resigns after 20 years; will join Nationwide Mutual board
Daniel Schurr resigned from CHS Board effective March 30, 2026, to join Nationwide Mutual Insurance Company's board.
-
CHS Q1 FY2026 net income $260.5M; revenue $8.9B; energy segment up, grains down
Net income $260.5M vs $244.8M YoY; revenue $8.9B vs $9.3B YoY.
-
CHS Inc. declares regular Q1 dividends on five preferred stock series
Regular quarterly dividends on five preferred series: CHSCP $0.50, CHSCO $0.492188, CHSCN $0.44375, CHSCM $0.421875, CHSCL $0.46875 per share.
-
CHS Inc. elects five directors, appoints C.J. Blew as new Board Chair
Five incumbent directors reelected to three-year terms: Holm, Throener, Clemensen, Farrell, Stroh.
-
CHS fiscal 2025 annual meeting CFO report; financial figures missing from filing
CFO Olivia Nelligan presented fiscal 2025 results at Dec 5, 2025 annual meeting.
-
CHS reports FY2025 net income $597.9M, down 46% from $1.1B; revenue falls to $35.5B
Consolidated revenues of $35.5B vs $39.3B in FY2024, driven by lower commodity prices.
-
CHS Inc. declares regular quarterly dividends on five preferred stock series payable Dec 31, 2025
Dividend of $0.50 per share on 8% Cumulative Redeemable Preferred Stock (CHSCP).
-
CHS announces FY2025 patronage: 35% to reserves, $30M cash to patrons, $90M equity redemptions
35% of FY2025 patronage earnings added to capital reserves.
-
CHS declares regular Q3 preferred dividends; payable Sep 30, 2025
$0.50 on 8% Cum. Redeemable (CHSCP); $0.492188 on Series 1 (CHSCO); $0.443750 on Series 2 (CHSCN)
-
CHS Inc. Amends Securitization and Repurchase Facilities, Extends Terms to August 2026
Added BBVA as a committed purchaser and extended receivables securitization facility term to August 26, 2026.
-
CHS schedules owners forums between July 18 and August 8, 2025; slide presentation furnished
Eight in-person owners forums from July 18 to August 6, 2025, plus virtual forum on August 8.
-
CHS Inc. Q3 net income $232.2M, down 22% YoY; Energy posts $50.1M pretax loss
Net income $232.2M (Q3 FY2025) vs $297.3M YoY; revenues $9.8B vs $9.6B.
-
CHS Q2 net loss $75.8M vs $170.3M income; revenue falls 14% to $7.8B
Net loss of $75.8M in Q2 FY2025, compared to net income of $170.3M in Q2 FY2024.
-
CHS Inc. declares regular quarterly dividends on five preferred stock series
Dividend of $0.50 per share on 8% Cumulative Redeemable Preferred Stock (CHSCP).
-
CHS Q1 net income falls 53% YoY to $244.8M; Energy segment earnings plunge $247M
Revenue $9.3B vs $11.4B YoY; net income $244.8M vs $522.9M.
-
CHS declares regular quarterly dividends on five preferred stock series
Dividends declared on five preferred stock series; all payable March 31, 2025.
-
CHS elects Trent Sherven and Chris Edgington to board; Schurr reelected chair
Trent Sherven elected to represent Region 3 (ND), succeeding retired director Steve Fritel.
-
CHS CFO presents fiscal 2024 financial report at annual meeting; no specific figures filed
Olivia Nelligan, EVP and CFO, gave speech and slide presentation on FY2024 results at December 6 annual meeting.
-
CHS reports FY2024 net income $1.1B, down 42% YoY; revenue $39.3B
Net income attributable to CHS Inc. of $1.10B vs $1.90B in FY2023; revenue $39.3B down from $45.6B.
-
CHS Inc. declares quarterly dividends on five preferred series, payable Dec 31
Declared regular dividends: $0.50 on 8% Cum Red Pfd, $0.492188 on Series 1, $0.443750 on Series 2, $0.421875 on Series 3, $0.468750 on Series 4.
-
CHS amends credit agreement to $300M revolver convertible to term loan
CHS converted $300M term loan into revolving facility with potential $250M accordion feature.
-
10% of FY2024 patronage earnings added to capital reserves; remainder distributed.
-
CHS declares regular quarterly dividends on five preferred series
Preferred dividends per share: $0.50 (CHSCP), $0.492188 (CHSCO), $0.443750 (CHSCN), $0.421875 (CHSCM), $0.468750 (CHSCL).
-
CHS Inc. extends receivables securitization and repurchase financing facilities to Aug 27, 2025
Receivables Purchase Agreement amended to extend facility term through August 27, 2025.
-
CHS holds virtual owners forums July 24-25; furnishes Q3 FY24 business update slide
Virtual owners forums held July 24 and July 25, 2024 for member owners.
-
CHS Q3 FY2024 net income $297M, down 46% YoY; revenue falls to $9.6B
Net income $297.3M vs $547.5M YoY; revenue $9.6B vs $12.0B, down 20%.
-
CHS Inc. enters into $700M note purchase agreement; notes mature 2032-2039 at rates 5.84%-6.13%
Series DD $150M at 5.84% due 2032; EE $150M at 5.93% due 2034; FF $150M at 6.05% due 2037; GG $250M at 6.13% due 2039.
-
CHS Q2 net income falls 42% to $170.3M; revenue down 19% to $9.1B
Net income $170.3M (down 42% YoY); revenue $9.1B (down 19% YoY).
-
Regular quarterly dividend declared on five preferred stock series.
-
CHS and GROWMARK end exploratory collaboration; no new opportunities pursued
CHS and GROWMARK entered an exploratory process in January 2024 to identify collaboration opportunities.
Materiality & sentiment trend
Max materiality 0.80 · Median 0.30 · Most common event earnings